ZEISS Doubles Down on Smart Eyewear with Stake in Finnish Eye-Tracking Start-Up
ZEISS Ventures leads a €2.2 million raise for SeeTrue Technologies, the latest move in the optics giant's push into connected eye health.
ZEISS is tightening its grip on the smart glasses race, with its venture capital arm confirming it has led a €2.2 million (approximately 3.6m A$) financing round for SeeTrue Technologies, a Finnish deep-tech company building miniaturised eye-tracking systems.
Announced earlier this month, the investment will help Joensuu-based SeeTrue push its ultra-low-power eye-sensing architecture toward commercial deployment. The company's pitch centres on shrinking eye-tracking hardware down to a scale that can realistically sit inside a pair of everyday-looking smart glasses, without the bulk and battery drain that has long dogged the category.
Solving the size-and-power problem
SeeTrue's approach pairs miniature sensing hardware with embedded processing tuned to run on minimal power, a combination the company says is grounded in the anatomy of the eye rather than brute-force computing. For device makers, that translates into gaze-tracking that fits into thinner frames while sipping less battery, a trade-off that has been one of the biggest engineering headaches in bringing XR and AI glasses to mass-market consumers.
Beyond wearables, SeeTrue is positioning the same underlying platform for healthcare optics and industrial applications, framing eye movement as a signal that can support attention-aware computing and workflow monitoring as much as consumer interaction.
Roman Bednarik, CEO and co-founder of SeeTrue, said the backing from ZEISS gives the start-up more than capital. It brings insight the company can draw on as it develops and commercialises its eye-detection platform in the years ahead.
Boris Hofmann, who heads ZEISS Ventures, said the Finnish company's fresh take on eye-tracking leaves it well placed to tackle some of the toughest problems in vision-based applications and to help push human-machine interaction toward something more seamless.
Part of a broader connected-health play
The round also drew in Superhero Capital, the Redstone Nordics-managed North Karelia Growth Fund, photonics accelerator Luminate, industry veteran Piotr Frasunkiewicz, and several of SeeTrue's existing angel backers.
For ZEISS, the SeeTrue stake is the third connected-health move in short order. The group recently acquired Swiss company Vivior AG, whose frame-mounted sensors track wearers' real-world visual behaviour, and ZEISS Ventures has separately backed hearing-tech start-up Vibrosonic. Taken together, the deals point to a company using its venture arm to build out a broader digital health footprint that extends well beyond traditional lens and instrument manufacturing.
For eyecare professionals, the direction of travel is worth watching closely. If eye-tracking hardware genuinely shrinks to the point of disappearing into standard frames, it could open a new category of vision-adjacent data, attention, gaze behaviour, visual workload, that practices may eventually be asked to interpret or integrate into patient care, well before such devices reach optical retail shelves in volume.